Autism therapy has become the fastest-growing area of spending for Medicaid, the state-run program for low-income people. In 2023, states paid autism-therapy providers $2.2 billion, up from just $660 ...

Autism is a spectrum. This metaphor is a helpful way to explain why autism looks and feels so varied across different people. Since 2013 it’s been baked into the name of the diagnosis itself, autism ...

The Food and Drug Administration approved a decades-old prescription vitamin called leucovorin as the first treatment for a rare genetic disorder in certain adults and children. The move comes months ...

Corrections and clarifications: Due to an editing error, a previous version of this story mischaracterized the scope of the new FDA approval for leucovorin. In a White House briefing on Sept. 22, ...

The Food and Drug Administration does not have sufficient evidence to back the use of the generic drug leucovorin for treating children with autism, two senior agency officials told reporters Monday.

The Food and Drug Administration on Tuesday announced a new approved use for the drug leucovorin, a synthetic form of vitamin B9 that the Trump administration has touted as a treatment for autism ...

The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they ...

When Meghann Mitchell first launched her autism-therapy business in 2019, she took aim at an unlikely source of profit: Indiana’s taxpayer-funded Medicaid program, the public insurance system for the ...

Among 30 possible coded diagnoses, children and adolescents with autism had elevated rates of gastrointestinal (GI) disturbances, feeding problems, sleep difficulties, and anxiety disorders, according ...

Chelsea boss Enzo Maresca was proud of his players after their shock Club World Cup final triumph against PSG. Chelsea thumped PSG 3-0, with the European champions having Joao Neves sent off late on.

Washington — The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral folate deficiency, but not for children with the much ...